Join this Featured Workgroup!
Elite Investors

This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.

In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.

In your application messsage, please share your background and what you can contribute to the group.



Company Overview and News

0
Selecting An Alternative Strategy

16h blog.invesco.us
I've written this summer about the potential benefits of alternative investments. Let's assume that readers of my previous blogs agree that my ideas have some merit and it is time to diversify into alternatives (alts). The devil is always in the details. Of all the different alt funds available, which is best for a given investor? And where does it fit in a portfolio? In this blog, the fourth in my series explaining the basics of alts, I will suggest a process that may help investors select the best alternative strategy for their objectives.
IVZ

0
What Currency Pressures In Turkey And Other Countries May Mean For Investors

19h blog.invesco.us
Posted by Kristina Hooper, Chief Global Market Strategist on Aug 13, 2018, in Market & Economic
COT IVZ

0
IVZ / Invesco Ltd. FORM S-3ASR

2018-08-14 sec.gov
Form S-3ASR Table of Contents As filed with the Securities and Exchange Commission on August 14, 2018. Registration No. 333-
IVZ

0
IVZ / Invesco Ltd. FORM S-3ASR

2018-08-14 sec.gov
Form S-3ASR Table of Contents As filed with the Securities and Exchange Commission on August 14, 2018. Registration No. 333-
IVZ

0
IVZ / Invesco Ltd. FORM S-3ASR

2018-08-14 sec.gov
Form S-3ASR Table of Contents As filed with the Securities and Exchange Commission on August 14, 2018. Registration No. 333-
IVZ

3
Legg Mason's (LM) July AUM Increases on Higher Equity Assets

2018-08-13 zacks
Legg Mason Inc. (LM - Free Report) has reported an increase in assets under management (AUM), as of Jul 31, 2018, compared with the previous month. Preliminary month-end AUM came in at $749.2 billion, higher than the June 2018 figure of $744.6 billion. The July AUM displayed $1.9-billion net fixed income outflows, along with equity net outflows of $0.5 billion and $0.6 billion of alternative outflows.
FOX CNS BEN LMHA LMHB FOXA LM IVZ

0
T. Rowe Price (TROW) Reports Sequential Growth in July AUM

2018-08-13 zacks
T. Rowe Price Group, Inc. (TROW - Free Report) announced preliminary assets under management (AUM) of $1.07 trillion for July 2018. Results reflect nearly 2.9% rise from $1.04 trillion recorded on Jun 30, 2018. Client transfers from mutual funds to other portfolios, including trusts and separate accounts, were $0.5 billion in July. Month-end total sponsored U.S. mutual funds came in at $638 billion, up 1.
CNS BEN IVZ

0
What Could A Trade War Mean For U.S. Macro Fundamentals?

2018-08-12 blog.invesco.us
The growing prospect of a global trade war presents major consequences for global markets, and the implications are difficult to assess. Because the past 30 years have consisted of generally expanding trade liberalization and global trade (shown in Figure 1), we are left with limited information on how financial markets would likely respond. Below, I discuss Invesco Fixed Income's view of how the situation could affect US macro fundamentals, and I highlight the potential impact on fixed income markets.
IVZ

0
How Factors May Help Bond Investors Reach Their Goals

2018-08-12 blog.invesco.us
By Jay Raol, Director of Quantitative Research, Invesco Fixed Income on Aug 7, 2018, in Fixed Income
IVZ

224
S&P 500: It's All In The Numbers And The Numbers Never Lie

2018-08-12 seekingalpha
We all talk much about FAANG and/or the tech sector. However, the market is far greater and more interesting than that.
SYMC XOM CVS WMT NWL AMZN CAH TSN BAC CHLKF AAL INCY 0941 BRK.A BHF CHL GOOGL JNJ MSFT MHK WFCNP FB ALB MCK NLSN LB BAC TSNU AAPL GM MCD WFC COST ABC V XRAY CVX UNH IVZ COTY

0
IVZ / Invesco Ltd. 8-K (Current Report)

2018-08-11 sec.gov
Document UNITED STATES
IVZ

100
ETB / Eaton Vance Tax-Managed Buy-Write Income Fund - Stock Institutional Ownership and Shareholders - Fintel.io

2018-08-10 fintel.io
This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.
WFCNP ETB NYMX EV AMP TWMJF UBS WEED MS WFC PNCFO CGC PNC PNUCL ULSGF IVZ

0
MLPs: A Light At The End Of The Pipeline

2018-08-10 blog.invesco.us
By David Wertheim, Senior Client Portfolio Manager and Darin Turner, Managing Director and Portfolio Manager on Aug 9, 2018, in Alternatives
IVZ

0
Currency Outlook: We Expect U.S. Dollar Appreciation Due To Trade Tensions

2018-08-09 blog.invesco.us
Posted by Ray Uy, Head of Macro Research and Currency Portfolio Management on Aug 8, 2018, in Fixed Income
IVZ

0
Interest Rate Outlook: Strong U.S. GDP Growth, Trade Worries May Keep Rates Range-Bound In 2018

2018-08-09 blog.invesco.us
Posted by Rob Waldner, Chief Strategist and Head of Multi-Sector on Aug 8, 2018, in Fixed Income
IVZ

Related Articles

BLDP: Ballard Power Systems Analysis and Research Report

2018-08-13 - Asif

Core Business At Ballard, Ballard Power Systems is building a clean energy growth company. Ballard Power Systems is recognized as a world leader in proton exchange membrane (“PEM”) fuel cell power system development and commercialization. The company's principal business is the design, development, manufacture, sale and service of PEM fuel cell products for a variety of applications, focusing on its power product markets of Heavy-Duty Motive (consisting of bus, truck, rail and marine applications), Portable Power, Material Handling and Backup Power, as well as the delivery of Technology Solutions, including engineering services, technology transfer, and the license and sale of its extensive intellectual property portfolio and fundamental knowledge for a variety of fuel cell applications. A fuel cell is an environmentally clean electrochemical device that combines hydrogen fuel with oxygen (from the air) to produce electricity. The hydrogen fuel can be obtained from natural g...

MARA: Marathon Patent Group Analysis and Research Report

2018-08-13 - Asif

Overview Marathon Patent Group was incorporated in the State of Nevada on February 23, 2010 under the name Verve Ventures, Inc. On December 7, 2011, the company changed its name to American Strategic Minerals Corporation and were engaged in exploration and potential development of uranium and vanadium minerals business. In June 2012, the company discontinued its minerals business and began to invest in real estate properties in Southern California. In October 2012, the company discontinued its real estate business when its former CEO joined the firm and the company commenced its IP licensing operations, at which time the Company’s name was changed to Marathon Patent Group, Inc. On November 1, 2017, the company entered into a merger agreement with Global Bit Ventures, Inc. (“GBV”), which is focused on mining digital assets. Marathon Patent Group has since purchased its cryptocurrency mining machines and established a data center in Canada to mine digital assets. Following the me...

ECYT: Endocyte Analysis and Research Report

2018-08-13 - Asif

Business and Organization Endocyte, Inc. is a biopharmaceutical company and leader in developing targeted therapies for the treatment of cancer. The Company uses drug conjugation technology to create novel therapeutics and companion imaging agents for personalized targeted therapies. The agents actively target receptors that are over-expressed on diseased cells relative to healthy cells, such as prostate specific membrane antigen (“PSMA”) in prostate cancer. This targeted approach is designed to safely enable the delivery of highly potent drug payloads. The companion imaging agents are designed to identify patients whose disease over-expresses the target of the therapy and who are therefore more likely to benefit from treatment. In September 2017, the Company entered into a Development and License Agreement (the “License Agreement”) with ABX advanced biochemical compounds – Biomedizinische Forschungsreagenzien GmbH (“ABX”), pursuant to which the Company acquired exclusive ...

CUSIP: G491BT108